Medtronic’s money keeps flowing with CardioInsight buy, Arsenal investment
This article was originally published in Clinica
Medtronic has expanded its cardiac rhythm management offerings with the $93m acquisition of CardioInsight Technologies, a heart mapping technology specialist. The move marks Medtronic’s fourth bolt-on acquisition this year to date, and the first for its biggest business group, Cardiac and Vascular.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.